Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
14.81
+0.06 (0.41%)
Sep 4, 2025, 2:26 PM - Market open
Orthofix Medical Market Cap
Orthofix Medical has a market cap or net worth of $584.91 million as of September 4, 2025. Its market cap has decreased by -5.06% in one year.
Market Cap
584.91M
Enterprise Value
714.96M
1-Year Change
-5.06%
Ranking
Category
Stock Price
$14.81
Market Cap Chart
Since December 1, 1998, Orthofix Medical's market cap has increased from $145.80M to $584.91M, an increase of 301.17%. That is a compound annual growth rate of 5.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 582.50M | -12.69% |
Dec 31, 2024 | 667.20M | 34.65% |
Dec 29, 2023 | 495.50M | 20.62% |
Dec 30, 2022 | 410.80M | -33.08% |
Dec 31, 2021 | 613.90M | -26.13% |
Dec 31, 2020 | 831.00M | -5.57% |
Dec 31, 2019 | 880.00M | -11.40% |
Dec 31, 2018 | 993.20M | -0.41% |
Dec 29, 2017 | 997.30M | 54.64% |
Dec 30, 2016 | 644.90M | -12.93% |
Dec 31, 2015 | 740.70M | 33.65% |
Dec 31, 2014 | 554.20M | 24.85% |
Dec 31, 2013 | 443.90M | -41.58% |
Dec 31, 2012 | 759.90M | 17.16% |
Dec 30, 2011 | 648.60M | 26.16% |
Dec 31, 2010 | 514.10M | -3.00% |
Dec 31, 2009 | 530.00M | 102.14% |
Dec 31, 2008 | 262.20M | -73.29% |
Dec 31, 2007 | 981.70M | 19.78% |
Dec 29, 2006 | 819.60M | 28.36% |
Dec 30, 2005 | 638.50M | 4.30% |
Dec 31, 2004 | 612.20M | -12.12% |
Dec 31, 2003 | 696.60M | 93.34% |
Dec 31, 2002 | 360.30M | -26.47% |
Dec 31, 2001 | 490.00M | 96.63% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 660.01B |
Johnson & Johnson | 428.83B |
AbbVie | 374.37B |
UnitedHealth Group | 279.67B |
Novo Nordisk | 248.91B |
AstraZeneca | 247.16B |
Novartis AG | 244.04B |
Abbott Laboratories | 228.80B |